Pic: via Getty Images
In Case You Missed It: R&D refunds for drug developers and a major uranium merger
News
share
Stockhead’s In-Case-You-Missed-It highlights today’s most interesting small cap stories that might have slipped beneath your radar.
Below is a wrap of the top 20 performing stocks, by percentage, that made announcements today.
ICYMI Leader Board
| Code | Company | Price | % Today | Market Cap |
|---|---|---|---|---|
| NYR | Nyrada Inc. | 0.026 | 30% | $3,120,174 |
| 92E | 92Energy | 0.455 | 25% | $38,826,912 |
| EYE | Nova EYE Medical Ltd | 0.135 | 17% | $21,922,323 |
| HCT | Holista CollTech Ltd | 0.014 | 17% | $3,345,601 |
| PNN | Power Minerals Ltd | 0.23 | 15% | $17,468,462 |
| OSL | Oncosil Medical | 0.009 | 13% | $15,796,329 |
| NAG | Nagambie Resources | 0.032 | 10% | $16,870,063 |
| XAM | Xanadu Mines Ltd | 0.054 | 10% | $83,340,213 |
| IXC | Invex Ther | 0.07 | 10% | $4,787,300 |
| BAT | Battery Minerals Ltd | 0.038 | 9% | $4,186,157 |
| BMR | Ballymore Resources | 0.14 | 8% | $20,976,377 |
| CTE | Cryosite Limited | 0.6 | 7% | $27,333,355 |
| WCG | Webcentral Ltd | 0.255 | 6% | $80,172,295 |
| LM8 | Lunnonmetalslimited | 0.69 | 6% | $141,086,557 |
| FBM | Future Battery | 0.074 | 6% | $37,362,919 |
| RKT | Rocketdna Ltd. | 0.0095 | 6% | $4,805,034 |
| E33 | East 33 Limited. | 0.02 | 5% | $10,204,685 |
| TLM | Talisman Mining | 0.21 | 5% | $37,664,070 |
| NRZ | Neurizer Ltd | 0.022 | 5% | $28,496,690 |
| DSK | Dusk Group | 0.99 | 5% | $58,843,132 |
Cardiovascular and neurological drug development company Nyrada (ASX:NYR) has received a A$3,541,731 cash rebate from the Australian Federal Government’s Research & Development (R&D) tax incentive program.
92 Energy (ASX:92E) is merging with TSX-listed ATHA Energy at an implied 78% premium to the last 92E share price, and 70% premium to the 30-day VWAP.
Nova Eye Medical (ASX:EYE) says five MACs (Medicare Administrative Contractors) have deferred the proposed USA reimbursement changes from 23 December 2023, to January 29, 2024 – which is a positive outcome for the near-term sales of the company’s iTrack portfolio of canaloplasty devices, which continue to be strong since the US launch of iTrack Advance in May.
Holista CollTech (ASX:HCT) says the judge overseeing the Federal Court stoush between the company and the Australian Securities and Investments Commission pulled the pin on proceedings a day earlier than expected. No decision has been announced.
And pancreatic cancer medical device company OncoSil Medical (ASX:OSL) says the first initial commercial treatments involving the OncoSil device in Greece have just commenced at a renowned hospital in Athens.
More Top Small Cap Stories: Friday
Vulcan Energy (ASX:VUL) has receive a positive Environmental and Social Impact Assessment (EISA) which opens the door to ‘green’ financing pathways for its Zero Carbon Lithium project in Germany.
Future Battery Minerals (ASX:FBM) has commenced RC drilling at its Nevada lithium project, ahead of a maiden resource definition next year.
First Lithium (ASX:FL1) says diamond core drilling at its Blakala lithium prospect in Mali, Africa, now totals 2,300m with over 911m of spodumene bearing pegmatite intersected to date.
Elevate Uranium (ASX:EL8) has received binding commitments to raise $10m via a placement at $0.42 per share for resource definition and expansion drilling across its Namibian and Australian uranium portfolio.
Dynamic Metals (ASX:DYM) has completed phase 2 nickel drilling at its Lake Percy project in WA, with assays expected in January 2024.
And New World Resources (ASX:NWC) has picked up 1,000 acres of additional mineral rights along strike from its Antler copper deposit in Arizona, USA.
At Stockhead we tell it like it is. While Vulcan Energy Resources, Dynamic Metals, Future Battery Minerals, First Lithium, Elevate Uranium and New World Resources are Stockhead advertisers, they did not sponsor this article.
Read MoreAusbiotech
